Latest chemotherapy News

Giardiasis cases are rising in England: should we be worried?
AstraZeneca completes global license agreement for oral EGFR inhibitor Zegfrovy for lung cancer
Enhertu plus pertuzumab approved in the EU as first new regimen in more than a decade for the 1st-line treatment of patients…
New treatment option on the PBS for locally advanced or metastatic bladder cancer
Learning To Live Without Stomach: Jason’s Cancer Shock
Cancer’s Malignant Remote Control
Folic acid does not elevate formaldehyde in mice and humans
Standard breast cancer classification may overlook important differences
FDA approves breakthrough pancreatic cancer drug – an oncologist explains how daraxonrasib nearly doubles survival
AI Helps Identify Regulatory Hub for Aging in Hematopoietic Stem Cells
Walking 7 Bridges Together To Tackle Cancer
Lung cancer patient became tumour-free after treatment with selenite
Blood-Camouflaged Liquid Metal Nanoparticles Defeat the Most Aggressive Breast Cancer
Two weeks to go: Nathan is already saving lives in The Long Run
Enhertu demonstrated statistically significant and clinically meaningful improvement in progression-free survival as 1st-line treatment of patients with HER2-mutant advanced non-small cell lung…
Update on eVOLVE-Lung02 Phase III trial of volrustomig plus chemotherapy in metastatic non-small cell lung cancer
Regional differences in chemotherapy treatment for breast cancer may affect survival
New intake of paramedics and control staff for NSW Ambulance
Getting Full Picture On PSMA PET/CT Scans
First new treatment in more than 20 years for rare, incurable brain cancer, listed on the PBS
Brain cancer Achilles heel revealed in the hours after surgery
Some animals catch cancer from others in their species – here’s why humans aren’t one of them
Enhertu plus pertuzumab recommended for approval in the EU by CHMP as 1st-line treatment for patients with HER2-positive metastatic breast cancer
HKUST Develops New Biocompatible Chemical Reaction to Advance Next-Generation Anticancer Prodrugs
Former Wheatbelt local leads charge for cancer research appeal
Smouldering myeloma: Lauren Laverne’s diagnosis explained
Delivering Better Healthcare For Bass Coast Locals
Pacific women call for better cancer education and culturally responsive care
AstraZeneca enters exclusive global license agreement for novel oral EGFR inhibitor Zegfrovy for lung cancer with Dizal Pharmaceutical
New Frankston Hospital Helps Thousands Of Victorians
Australian cancer trials are getting worse at reporting sex differences – putting patients at risk
Scientists uncover promising new way to treat an ‘undruggable’ type of lung cancer
Major Day Oncology Expansion At Epworth Geelong
Darolutamide (Nubeqa) – Hope for men with high-risk non-metastatic hormone resistant prostate cancer
Living With Childhood Brain Tumour: Coen’s Story
Fertility after a cancer diagnosis: Your questions answered
Bumper month for cheaper medicines with 10 new PBS listings for July
Datroway recommended for approval in the EU by CHMP as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not…
New research makes critical discovery for the global fight against antibiotic resistance
Leukaemia Foundation labels Queensland Government’s review of the Patient Travel Subsidy Scheme incomplete
Hidden Isolation Of Rare Cancer Diagnosis
World-leading research receives cash boost in Manchester
TGA Product Information Safety Updates 15 June
New acute care and cancer treatment services for Dargaville
When the diagnosis is on the other side: Priyal’s unexpected breast cancer experience  
Metal-free carbon monoxide treatment may help prevent cancer’s deadly spread
Kon’s Story Of Resilience Through Odds
Breakthrough steroid tweak cuts early deaths in Indian children with leukaemia